Sustained-Release Theophylline Preparations: Pitfalls in Generic Prescribing

  • A. T. Florence
Conference paper


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bochsler HP, Meyer UA (1982) Bioverfiigbarkeit von drei Theophyllin-Praparaten mit verzogerter Freisetzung. Schweiz Med Wochenschr 112: 1702–1710PubMedGoogle Scholar
  2. Boxenbaum H (1984) Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms. Pharm Res 2: 82–88CrossRefGoogle Scholar
  3. Chopra MP, Addison JM, Chopra A, Higginbottom A (1982) Plasma and saliva theophylline levels and pulmonary function in asthmatic patients after a sustained release theophylline preparation-Nuelin SA. Curr Med Res Opin 7: 624–630CrossRefGoogle Scholar
  4. Chrystyn H, Mulley BA, Peake MD (1984) Precise individualisation of theophylline dosage using a nomogram and Baysian analysis and dependence of accuracy on preparation used. R Soc Med Int Congr Symp Series 78: 117–125Google Scholar
  5. Dederich RA, Szefler SJ, Green ER (1981) Intra-subject variation in sustained-release theophylline absorption. J Allergy Clin Immunol 67: 465–471PubMedCrossRefGoogle Scholar
  6. Edwards C, Cope AS, Jackson AH, Purkiss R (1983) The comparative bioavailability of slow release oral theophylline preparations. J Clin Hosp Pharm 8: 63PubMedGoogle Scholar
  7. French IW, Mildon CA (1979) The pharmacokinetics of theophylline. Curr Med Res Opin 6 (Suppl 6): 3CrossRefGoogle Scholar
  8. Hendeles L, Iafrate RP, Weinberger M (1984) A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products. Clin Pharmacokinet 9: 95–135PubMedCrossRefGoogle Scholar
  9. Hendeles L, Weinberger M (1983) Theophylline: a state of the art review. Pharmacotherapy 3: 2–44PubMedGoogle Scholar
  10. Hendeles L, Weinberger M, Bighley L (1977) Absolute bioavailability of oral theophylline. Am J Hosp Pharm 34: 525–527PubMedGoogle Scholar
  11. Hendeles L, Wubbena P, Weinberger M (1984) Food-induced dose dumping of once-a-day theophylline. Lancet II: 1471Google Scholar
  12. Howarth PH, George CF (1983) Adverse effects of bronchodilator drugs. Adv Drug React Ac Pois Rev 2: 25–49Google Scholar
  13. Iafrate RP, Massey KL, Hendeles L (1986) Current Concepts in clinical therapeutics: Asthma. Clin Pharm 5: 206–227Google Scholar
  14. De Leede LG, De Boer AG, van Velzen SL, Breimer DD (1982) Zero-order rectal delivery of theophylline in man with an osmotic system. J Pharmacokinet Biopharm 10: 525–537PubMedCrossRefGoogle Scholar
  15. Leslie ST (1981) Continus controlled-release preparations. Br J Clin Pract (Symp Suppl) 10: 5–8Google Scholar
  16. Mucklow JC, Kuhn S (1985) The rise and fall of serum theophylline concentration: a comparison of sustained release formulations in volunteers with rapid theophylline clearance. Br J Clin Pharmacol 20: 589–596PubMedGoogle Scholar
  17. Pedersen S, Moeller-Petersen J (1982) Influence of food on the absorption rate and bioavailability of a sustained release theophylline preparation. Allergy 37: 531–534PubMedCrossRefGoogle Scholar
  18. Russell CJ, Elwood RK, Kinney C, McDevitt DG (1980) Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained- release theophylline preparation to normal subjects. Eur J Clin Pharmacol 18: 351PubMedCrossRefGoogle Scholar
  19. Summers RS, Summers B, Rawnsley S (1986) The bioavailability, absorption characteristics and formulation of four commercially-available controlled release theophylline products. Int J Pharm 30: 83–88CrossRefGoogle Scholar
  20. Toennesen J (1981) Oral theophylline and fatal asthma. Lancet II: 200Google Scholar
  21. Turner-Warwick M, Levy J (eds) (1984) New Perspectives in Theophylline Therapy. R Soc Med Symp Series No. 78Google Scholar
  22. Weinberger MM, Hendeles L (1983) Slow release theophylline- rationale and basis for product selection. N Engl J Med 308: 760PubMedCrossRefGoogle Scholar
  23. Welling PG, Lyons LL, Craig WA, Trochta GA (1975) Influence of diet and fluid on bioavailability of theophylline. Clin Pharmacol Ther 17: 475PubMedGoogle Scholar
  24. Whiting B (1983) Controlling theophylline therapy. Lancet II: 966Google Scholar
  25. Woodcock AA, Johnston MA, Geddes DM (1983) Theophylline prescribing, serum concentrations and toxicity. Lancet 11: 610–612CrossRefGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg New York 1987

Authors and Affiliations

  • A. T. Florence

There are no affiliations available

Personalised recommendations